Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

Left ventricular mass (LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus and quantitative trait transcript (QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin (Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of ∼22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.

[1]  Enrico Petretto,et al.  Heritability and Tissue Specificity of Expression Quantitative Trait Loci , 2006, PLoS genetics.

[2]  S. Cook,et al.  Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. , 1999, Circulation research.

[3]  R. Duisters,et al.  Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy , 2004, Circulation research.

[4]  K. Chien,et al.  Mixed signals in heart failure: cancer rules. , 2002, The Journal of clinical investigation.

[5]  L. Almasy,et al.  Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes , 2007, Nature Genetics.

[6]  Pamela S Douglas,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Circulation.

[7]  B. Howard,et al.  Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. , 1997, Circulation.

[8]  Y. Ahn,et al.  A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.

[9]  C. Haley,et al.  Genetical genomics in humans and model organisms. , 2005, Trends in genetics : TIG.

[10]  K. Fujiwara,et al.  ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[13]  Alan S. Pearlman,et al.  ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[15]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[16]  Hans Kresse,et al.  Proteoglycans of the extracellular matrix and growth control , 2001, Journal of cellular physiology.

[17]  Y. Imai,et al.  Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. , 2007, American journal of hypertension.

[18]  Paul A. Overbeek,et al.  TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.

[19]  M. Spence,et al.  Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains. , 1995, The Journal of clinical investigation.

[20]  R. Duisters,et al.  Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy , 2007, The Journal of experimental medicine.

[21]  G. Dorn,et al.  Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling , 2007, Circulation research.

[22]  D. Levy,et al.  Heritability of left ventricular mass: the Framingham Heart Study. , 1997, Hypertension.

[23]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[24]  E. Petretto,et al.  Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease , 2005, Nature Genetics.

[25]  E. Foster,et al.  The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse , 2003 .

[26]  Richard T. Lee,et al.  Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity , 2004, Circulation.

[27]  E. Tasheva,et al.  Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. , 2002, Molecular vision.

[28]  G. Gibson,et al.  Quantitative trait transcripts for nicotine resistance in Drosophila melanogaster , 2007, Nature Genetics.

[29]  E. Tasheva,et al.  Differential Splicing and Alternative Polyadenylation Generate Multiple Mimecan mRNA Transcripts* , 1997, The Journal of Biological Chemistry.

[30]  W. Hodroj,et al.  Transcriptional alterations in the left ventricle of three hypertensive rat models. , 2006, Physiological genomics.

[31]  S. Caruthers,et al.  Practical Value of Cardiac Magnetic Resonance Imaging for Clinical Quantification of Aortic Valve Stenosis: Comparison With Echocardiography , 2003, Circulation.